le 30 juillet/July 2019

	The common shares of XPhyto Therapeutics Corp. have been approved for listing on the CSE.

	Listing and disclosure documents will be available at&nbsp;<a href="https://thecse.com/en/listings/life-sciences/xphyto-therapeutics-corp">www.thecse.com</a>&nbsp;on the trading date.

	XPhyto is a science-focused cannabis company developing analytical testing, processing, and formulation capability in Canada and research, cultivation, extraction, import, distribution, and manufacturing in Germany. Two exclusive 5-year engagements with the Faculty of Pharmacy at a major Canadian university provide certified analytical testing capability, as well as extraction, isolation, and formulation facilities, and drug research and development expertise. XPhyto acquired 100% ownership of the German cannabis company Bunker Pflanzenextrakte GmbH, which has been granted a cannabis cultivation and extraction licence for scientific purposes by BfArM, the German Federal Institute for Drugs and Medical Devices.

	________________________

	Les actions ordinaires de XPhyto Therapeutics Corp. ont été approuvées à la cote du CSE.

	Les documents de cotation et d'information seront disponibles sur&nbsp;<a href="https://thecse.com/fr/inscriptions/sciences-biologiques/xphyto-therapeutics-corp">www.thecse.com</a>&nbsp;à la date de négociation.

	XPhyto est une entreprise de cannabis axée sur la science qui développe des capacités d'analyse en matière de tests, de transformation et de formulation au Canada et de recherche, de culture, d'extraction, d'importation, de distribution et de fabrication en Allemagne. Deux engagements exclusifs de cinq ans avec la Faculté de pharmacie d'une grande université canadienne fournissent une capacité d'analyse certifiée, ainsi que des installations d'extraction, d'isolement et de formulation, ainsi qu'une expertise en recherche et développement de médicaments. XPhyto a acquis la propriété à 100% de la société allemande de cannabis Bunker Pflanzenextrakte GmbH, qui a obtenu une licence de culture et d'extraction de cannabis à des fins scientifiques par bfArM, l'Institut fédéral allemand des drogues et des dispositifs médicaux.

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	
<table border="1" cellpadding="1" cellspacing="1" >
<tbody >
<tr >
<td >
				Issuer/Émetteur:</td>
<td >
				XPhyto Therapeutics Corp.</td>
</tr>
<tr >
<td >
				Security Type/Titre:</td>
<td >
				Common&nbsp;Shares/Actions&nbsp;ordinaires</td>
</tr>
<tr >
<td >
				Symbol(s)/Symbole(s):</td>
<td >
				XPHY</td>
</tr>
<tr >
<td >
				Number of securities issued and outstanding/&nbsp;Titres&nbsp;émis&nbsp;et en circulation:</td>
<td >
				47 107 705</td>
</tr>
<tr >
<td >
				Number of Securities reserved for issuance/&nbsp;Titres&nbsp;réservés&nbsp;pour&nbsp;émission:</td>
<td >
				24 041 105</td>
</tr>
<tr >
<td >
				CSE Sector/Catégorie:</td>
<td >
				Life Sciences/Sciences biologiques</td>
</tr>
<tr >
<td >
				CUSIP:</td>
<td >
				98421R 10 5</td>
</tr>
<tr >
<td >
				ISIN:</td>
<td >
				CA 98421R 10 5 5</td>
</tr>
<tr >
<td >
				Boardlot/Quotité:</td>
<td >
				500</td>
</tr>
<tr >
<td >
				Trading&nbsp;Currency/Monnaie&nbsp;de&nbsp;négociation:</td>
<td >
				CDN$/$CDN</td>
</tr>
<tr>
<td >
				Listing Date/Date de l’inscription:</td>
<td >
				le 31 juillet/July 2019</td>
</tr>
<tr >
<td >
				Trading Date/Date de&nbsp;negociation:</td>
<td >
				le 6&nbsp;août/August 2019</td>
</tr>
<tr >
<td >
				Other Exchanges/Autres&nbsp;marches:</td>
<td >
				N/A</td>
</tr>
<tr >
<td >
				Fiscal Year&nbsp;end /Clôture&nbsp;de&nbsp;l'exercice&nbsp;financier:</td>
<td >
				Le 31 décembre/December</td>
</tr>
<tr >
<td >
				Transfer Agent/Agent des&nbsp;transferts:</td>
<td >
				Computershare Investor Services Inc.</td>
</tr>
</tbody>
</table>

	The Exchange is accepting Market Maker applications for XPHY. Please email:&nbsp;<a href="mailto:Trading@theCSE.com">Trading@theCSE.com</a>

	If you have any questions&nbsp;or require further information please contact Listings at (416) 367-7340 or E-mail:&nbsp;<a href="mailto:Listings@thecse.com">Listings@thecse.com</a>

	Pour&nbsp;toute&nbsp;question, pour&nbsp;obtenir&nbsp;de&nbsp;l’information&nbsp;supplémentaire&nbsp;veuillez&nbsp;communiquer&nbsp;avec&nbsp;le service des inscriptions au 416 367-7340 ou par&nbsp;courriel&nbsp;à&nbsp;l’adresse:&nbsp;&nbsp;<a href="mailto:Listings@thecse.com">Listings@thecse.com</a>

BioNxt Solutions Inc.

2019-0724 – New Listing - XPhyto Therapeutics Corp. (XPHY)

CSE25™

CSE Composite Index®

In this series, we delve deep into the experiences of CSE listed companies, exploring their past successes and future opportunities.

CSE Issuer Spotlight

**Follow us** for the **latest news** from the CSE

 The CSE provides a modern and efficient alternative for companies looking to access the Canadian public capital markets.

The Canadian Securities Exchange (CSE)

Learn how we streamline issuer regulation through enhanced disclosure, practical and effective regulatory oversight, and modern technology.

Listing on the CSE

Learn more about the companies we list and how to get started trading on the CSE.

Investing in Listed Companies

Learn how we lower costs, reduce complexity, and provide market making opportunities for the dealer community.

Trading on the CSE

Whether you’re an investor, business leader, or simply looking to learn more, start your journey with the CSE here.

Get Started

From announcements and market updates to in-depth interviews with company leaders - stay informed with the latest from the CSE.

Latest from the CSE

Discover newly listed companies on the CSE through our series of bite-sized interviews with company leaders.

Get to know our latest listings

Listed Company News

Market Activity

List with the CSE

Find a home for your next big idea.

Frequently Asked Questions

How does being listed on the CSE affect me as a shareholder?

Where do I get information and trade CSE listed securities?

Where can I find an RSS feed for listed company news?

Where is the CSE recognized?

Upcoming Events

join the list

Join our mailing list to receive buy-in notifications

The CSE provides a superior exchange experience by investing in our customers’ success with innovation, dedication, and passion.

Where innovation, passion, and trust intersect

We strive to be the most innovative exchange in Canada. We aim to offer unlimited global access and a customized client-centric experience while delivering the lowest cost of public capital. 

We are Canada's entrepreneurial exchange

The most searched CSE listed companies on thecse.com

Recent Quotes

Get the latest regulatory announcements from the CSE concerning its Listings Policies, Trading Rules and functionality and other important industry developments.

Notices

Get the latest information about new CSE listings, the appointment of Market Makers, market events, and other news.

Bulletins

Stay informed with CSE listed company news, providing transparency and accountability to shareholders and the public.

Company News

Stay Informed

The **total volume** traded on the CSE today is

Connect with our professionals and listing experts at industry events and conferences.